Medicine and Dentistry
Anticoagulation
11%
Arachnoid Cyst
22%
Biopsy Technique
27%
Brain Stem Tumor
11%
Brainstem
11%
Burnout
11%
Central Nervous System Tumor
11%
Cerebral Venous Sinus Thrombosis
11%
Craniopharyngioma
11%
Cytokine
11%
Deterioration
12%
Ependymoma
27%
Fenestration
22%
Ganglioglioma
41%
Gunshot Injury
11%
Hydrocephalus
23%
Image-Guided Intervention
11%
Immunoglobulin
11%
Infarction
11%
Infection
25%
Intracranial Tumor
20%
Meningomyelocele
11%
Meta-Analysis
11%
Methylation
11%
Mucin
11%
Neoplasm
34%
Nerve Transplantation
11%
Neuroendoscopy
25%
Neurosurgery
22%
Next Generation Sequencing
11%
Pediatric Brain Tumor
35%
Pediatric Cancer
11%
Pediatrics
67%
Pediatrics Patient
41%
Pilocytic Astrocytoma
13%
Pontine Glioma
11%
Prematurity
13%
Radiation Therapy
17%
Reproducibility
11%
Stereotactic Biopsy
11%
Surgical Planning
11%
Systematic Review
100%
T Cell
11%
Third Ventriculostomy
33%
Transverse Myelitis
11%
Traumatic Brain Injury
11%
Tumor Biopsy
13%
Tumor Imaging
11%
Upper Limb
11%
Ventricle of Heart
17%
Keyphrases
Arachnoid Cyst
18%
Brain Tumor
13%
Brain Tumor Patients
13%
Career Burnout
22%
Career Satisfaction
22%
Cerebral Venous Sinus Thrombosis
11%
Clinical Data
12%
Cyst Fenestration
14%
Deep Learning
16%
Deep Learning Methods
11%
Dopamine
18%
Embase
15%
Endoscopic Third Ventriculostomy
33%
Flexible Neuroendoscopy
22%
Gene Panel Sequencing
11%
Glioma
11%
Glioma Patients
11%
Human Brain
15%
Human Disease
11%
Hydrocephalus
19%
Illustrative Case
22%
Immunobiology
11%
Medulloblastoma
13%
Meta-analysis
22%
Mouse Model
18%
Myxopapillary Ependymoma
22%
N-methylation
13%
Neurological Outcome
11%
Neurosurgeon
27%
Neurosurgery
23%
P-STAT3
11%
Parkinson's Disease
12%
Pediatric
38%
Pediatric Brain Tumor
47%
Pediatric Patients
45%
Pilocytic Astrocytoma
13%
PubMed
12%
Recurrent Malignant Glioma
11%
Salsolinol
11%
Scopus
12%
Serotonin
12%
Spinal Surgical Site Infections
11%
Survival Outcomes
11%
Systematic Literature Review
12%
Therapeutic Target
16%
Tumor
23%
Tumor Biopsy
13%
Visual Condition
11%
Visual Outcome
22%
WP1066
11%